These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11268740)

  • 1. [Spastic syndrome. More mobile again after stroke].
    MMW Fortschr Med; 2001 Mar; 143(10):46. PubMed ID: 11268740
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tolperisone in spasticity and muscle spasm. Tolperisone in multiple sclerosis].
    Nervenarzt; 1996 Jul; 67(7 Suppl Tolperison):1-4. PubMed ID: 9404528
    [No Abstract]   [Full Text] [Related]  

  • 3. [To make easier everyday life of stroke patients. Muscle relaxants diminish spasms].
    MMW Fortschr Med; 2003 Feb; 145(9):57. PubMed ID: 12666538
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness and safety of tolperisone in spasticity following cerebral stroke: randomized, double-blind, placebo-controlled trial].
    Lipták J
    Ideggyogy Sz; 2013 Jul; 66(7-8):283-4. PubMed ID: 23971362
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke.
    Stamenova P; Koytchev R; Kuhn K; Hansen C; Horvath F; Ramm S; Pongratz D
    Eur J Neurol; 2005 Jun; 12(6):453-61. PubMed ID: 15885050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of therapeutic response to baclofen vs tolperisone in spasticity.
    Agarwal S; Patel T; Shah N; Patel BM
    Biomed Pharmacother; 2017 Mar; 87():628-635. PubMed ID: 28086137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A randomized, double blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke].
    Stamenova P; Koytchev R; Kuhn K; Hanasen C; Horvath F; Ramm S; Pongratz D
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):34-42. PubMed ID: 16457132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative effectiveness of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity].
    Lipták J
    Ideggyogy Sz; 2013 Nov; 66(11-12):429. PubMed ID: 24555245
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of intrathecal baclofen in the treatment of spasticity in stroke].
    Lamotte D; Cantalloube S
    Ann Readapt Med Phys; 2007 Apr; 50(3):165-9. PubMed ID: 17145092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The administration of midocalm in the treatment of vertebrogenic algesic syndromes].
    Avakian GN; Chukanova EI; Nikonov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(5):26-31. PubMed ID: 10849963
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantification of the effects of muscle relaxant drugs in man by tonic stretch reflex.
    Meyer M; Adorjáni C
    Adv Neurol; 1983; 39():997-1011. PubMed ID: 6660131
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurophysiologic mechanisms of hemiplegic and paraplegic spasticity: implications for therapy.
    Herman R; Freedman W; Mayer N
    Arch Phys Med Rehabil; 1974 Aug; 55(8):338-43. PubMed ID: 4368954
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative efficacy of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity].
    Koval'chuk VV; Skoromets AA; Vasil'eva IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(8):14-9. PubMed ID: 18833102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Talperison in spasticity and and muscle rigidity].
    Orthopade; 1996 Aug; 25(4 Suppl):1-4. PubMed ID: 9022397
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of dantrolene sodium in the treatment of spasticity.
    Chipman M; Kaul S; Lambie M
    Dis Nerv Syst; 1974 Sep; 35(9):427-31. PubMed ID: 17894068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD].
    Kocsis P; Tarnawa I; Kovács G; Szombathelyi Z; Farkas S
    Acta Pharm Hung; 2002; 72(1):49-61. PubMed ID: 12426787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electromyographic control of the effects of a muscle relaxant: LCB 29 in pyramidal hypertonia].
    Cadilhac J; Daprès G
    Rev Electroencephalogr Neurophysiol Clin; 1972; 2(2):153-8. PubMed ID: 4681591
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of "Muscarum" in temporomandibular joint syndrome].
    Shirakawa M; Uzawa S; Shizume M; Wade H; Nakajima T
    Shikai Tenbo; 1979; 53(3):517-20. PubMed ID: 295974
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative effciency of bakloferon and tolperizon central muscle relaxants in complex therapy of back pain].
    Vorob'eva OV; Kozlova IM
    Voen Med Zh; 2006 Sep; 327(9):52-5. PubMed ID: 17180860
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of midocalm in combined treatment of neuropathic diabetic foot syndrome].
    Briskin BS; Sakunova TI; Iakobishvili IaI
    Khirurgiia (Mosk); 2000; (5):34-7. PubMed ID: 10842964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.